Ledger.Open graph →

SEC Form D · filed March 6, 2018

Tetherex Pharmaceuticals Corp

Offering

$50.0M

Sold

$43.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

OKLAHOMA CITY, OK

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Russell Rother, Ph.D · OKLAHOMA CITY, OKExec · Director Scott Rollins, Ph.D · OKLAHOMA CITY, OKExec · Director Richard Alvarez · Edmond, OKExec David Keiser · Madison, CTDirector Todd Foley · Boston, MADirector Rodger Mcever, M.D · OKLAHOMA CITY, OKDirector Jonathan Stocker, Ph.D · Cary, NCExec David Facloner · Edmond, OKExec Philip Jones, M.D · Norman, OKDirector Paul R. Mccullough · Minneapolis, MNExec Kevin Collings · Calgary, Alberta, CanadaExec Jurg Schappi · Dublin, IrelandExec Matthew S. Fisk · Minneapolis, MNExec · Director Philip Jones, M.D · Norman, OKDirector Nicolas Motelay · Dublin, IrelandDirector Randy Maksymowich · Calgary, Alberta, CanadaExec · Director Mark Poelzer · Calgary, Alberta, CanadaExec · Director James Davis · Calgary, Alberta, CanadaDirector Paul M. Britton · New York, NYExec · Director Corre Partners Management, LLC · New York, NYExec Arthur Rosen · New York, NYDirector Chandler Jones · Saco, MEExec · Director Richard L. Baum · Huntington, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗